Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Conjupro Biotherapeutics, Inc.
Protara Therapeutics
Atavistik Bio, Inc
Relmada Therapeutics, Inc.
K36 Therapeutics, Inc.
Centre Oscar Lambret
Centre Oscar Lambret
VA Office of Research and Development
Yonsei University
University of California, San Diego
Boston Scientific Corporation
The Methodist Hospital Research Institute
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
Relmada Therapeutics, Inc.
Alterome Therapeutics, Inc.
Amgen
University of Oklahoma
University College Cork
Peter MacCallum Cancer Centre, Australia
Nuvectis Pharma, Inc.
Psyence Australia Pty Ltd
ViroMissile, Inc.
Assistance Publique - Hôpitaux de Paris
Rutgers, The State University of New Jersey
Pfizer
Duke University
Wake Forest University Health Sciences
Cedars-Sinai Medical Center
University of Florida
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Janssen Research & Development, LLC
University of Arizona
Angiex, Inc.
St. Jude Children's Research Hospital
Werewolf Therapeutics, Inc.
Adaptimmune
Bristol-Myers Squibb
Unity Health Toronto
White River Junction Veterans Affairs Medical Center
Case Comprehensive Cancer Center
HealthPartners Institute
Ocellaris Pharma, Inc.
Novartis
RenJi Hospital
Var2 Pharmaceuticals
OncoNano Medicine, Inc.